ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Shuttle Pharmaceuticals Holdings Inc

Shuttle Pharmaceuticals Holdings Inc (SHPH)

0.6401
-0.0399
(-5.87%)
終了 12月21日 6:00AM
0.611
-0.0291
(-4.55%)
取引時間後: 9:58AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
0.611
買値
0.611
売値
0.68
出来高
118,936
0.6052 日の範囲 0.6943
0.58 52 週間の範囲 4.9464
時価総額
前日終値
0.68
始値
0.64
最終取引時間
財務取引量
US$ 76,646
VWAP
0.64443
平均取引量 (3 か月)
1,168,304
発行済株式数
3,664,919
配当利回り
-
PER
-0.36
1 株当たり利益 (EPS)
-1.8
歳入
-
純利益
-6.59M

Shuttle Pharmaceuticals Holdings Inc について

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surg... Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
本社
Wilmington, Delaware, USA
設立
-
Shuttle Pharmaceuticals Holdings Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker SHPH. The last closing price for Shuttle Pharmaceuticals was US$0.68. Over the last year, Shuttle Pharmaceuticals shares have traded in a share price range of US$ 0.58 to US$ 4.9464.

Shuttle Pharmaceuticals currently has 3,664,919 shares in issue. The market capitalisation of Shuttle Pharmaceuticals is US$2.49 million. Shuttle Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.36.

SHPH 最新ニュース

Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program

GAITHERSBURG, Md., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

GAITHERSBURG, Md., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty...

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

GAITHERSBURG, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty...

Shuttle Pharma Pays Off Senior Secured Convertible Note

GAITHERSBURG, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.109-15.13888888890.720.740.581989160.6707516CS
4-0.279-31.34831460670.890.9180.581077210.74071563CS
12-0.729-54.40298507461.342.250.5811683041.69625447CS
26-2.429-79.90131578953.044.160.589037572.08208922CS
52-3.149-83.753.764.94640.585138842.25761271CS
156-191.789-99.6824324324192.41010.080.5881785345.93488918CS
260-191.789-99.6824324324192.41010.080.5881785345.93488918CS

SHPH - Frequently Asked Questions (FAQ)

What is the current Shuttle Pharmaceuticals share price?
The current share price of Shuttle Pharmaceuticals is US$ 0.611
How many Shuttle Pharmaceuticals shares are in issue?
Shuttle Pharmaceuticals has 3,664,919 shares in issue
What is the market cap of Shuttle Pharmaceuticals?
The market capitalisation of Shuttle Pharmaceuticals is USD 2.49M
What is the 1 year trading range for Shuttle Pharmaceuticals share price?
Shuttle Pharmaceuticals has traded in the range of US$ 0.58 to US$ 4.9464 during the past year
What is the PE ratio of Shuttle Pharmaceuticals?
The price to earnings ratio of Shuttle Pharmaceuticals is -0.36
What is the reporting currency for Shuttle Pharmaceuticals?
Shuttle Pharmaceuticals reports financial results in USD
What is the latest annual profit for Shuttle Pharmaceuticals?
The latest annual profit of Shuttle Pharmaceuticals is USD -6.59M
What is the registered address of Shuttle Pharmaceuticals?
The registered address for Shuttle Pharmaceuticals is 1013 CENTRE ROAD SUITE 403-B, WILMINGTON, DELAWARE, 19805
Which industry sector does Shuttle Pharmaceuticals operate in?
Shuttle Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

SHPH Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock